Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

CRISPR-Cas Inhibits Natural Transformation Through Altruistic Group Defense and Self-Sacrifice

View ORCID ProfileRobert M. Cooper, Jeff Hasty
doi: https://doi.org/10.1101/2021.09.16.460680
Robert M. Cooper
1BioCircuits Institute; University of California, San Diego
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Robert M. Cooper
  • For correspondence: rcooper@ucsd.edu
Jeff Hasty
1BioCircuits Institute; University of California, San Diego
2Molecular Biology Section, Division of Biological Sciences; University of California, San Diego
3Department of Bioengineering; University of California, San Diego
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

Summary

CRISPR-Cas systems present an evolutionary tradeoff: does defense against phages and other parasitic DNA also prevent cells from acquiring potentially helpful new genes? Genomic analyses of this conundrum have arrived at often contradictory conclusions. Meanwhile, experimental studies have focused mainly on phages, conjugation, or artificial transformation, but less work has examined natural competence, a major driver of evolution and antibiotic resistance. Here, we use Acinetobacter baylyi, which combines high natural competence with a functional CRISPR-Cas system, to experimentally probe the interactions between CRISPR-Cas and natural competence. In these bacteria, the endogenous CRISPR array largely allows natural transformation by targeted DNA. However, CRISPR-Cas then kills the newly autoimmune cells in a form of programmed cell death. CRISPR-Cas often allows self-targeting cells to form colonies, albeit with fitness costs. Thus CRISPR-Cas appears to block natural transformation in a process more akin to altruistic group defense than an individual immune system.

Competing Interest Statement

J.H. is a co-founder and board member with equity in GenCirq Inc, which focuses on cancer therapeutics.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted September 16, 2021.
Download PDF

Supplementary Material

Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
CRISPR-Cas Inhibits Natural Transformation Through Altruistic Group Defense and Self-Sacrifice
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
CRISPR-Cas Inhibits Natural Transformation Through Altruistic Group Defense and Self-Sacrifice
Robert M. Cooper, Jeff Hasty
bioRxiv 2021.09.16.460680; doi: https://doi.org/10.1101/2021.09.16.460680
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
CRISPR-Cas Inhibits Natural Transformation Through Altruistic Group Defense and Self-Sacrifice
Robert M. Cooper, Jeff Hasty
bioRxiv 2021.09.16.460680; doi: https://doi.org/10.1101/2021.09.16.460680

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Molecular Biology
Subject Areas
All Articles
  • Animal Behavior and Cognition (4383)
  • Biochemistry (9599)
  • Bioengineering (7094)
  • Bioinformatics (24865)
  • Biophysics (12617)
  • Cancer Biology (9958)
  • Cell Biology (14357)
  • Clinical Trials (138)
  • Developmental Biology (7953)
  • Ecology (12107)
  • Epidemiology (2067)
  • Evolutionary Biology (15989)
  • Genetics (10926)
  • Genomics (14743)
  • Immunology (9870)
  • Microbiology (23677)
  • Molecular Biology (9485)
  • Neuroscience (50872)
  • Paleontology (369)
  • Pathology (1539)
  • Pharmacology and Toxicology (2683)
  • Physiology (4016)
  • Plant Biology (8657)
  • Scientific Communication and Education (1509)
  • Synthetic Biology (2397)
  • Systems Biology (6436)
  • Zoology (1346)